Elanco Animal Health Inc (NYSE:ELAN) has reported a 4% increase in revenue for Q3 2023, reaching $1,068 million. The revenue growth was driven by a 6% increase in Pet Health and...
Investing.com - Elanco Animal Health (NYSE: ELAN) reported third quarter EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.07B...
Investing.com - Elanco Animal Health (NYSE: ELAN) reported second quarter EPS of $0.18, $0.13 better than the analyst estimate of $0.05. Revenue for the quarter came in at $1.06B...
(Reuters) - Elanco Animal Health (NYSE:ELAN) said on Thursday the U.S. Environmental Protection Agency (EPA) has deemed the company's Seresto flea and tick collars for pets safe...
Investing.com - Elanco Animal Health (NYSE: ELAN) reported first quarter EPS of $0.45, $0.16 better than the analyst estimate of $0.29. Revenue for the quarter came in at $1.26B...
Elanco Animal Health (NYSE:ELAN) reported Q4 EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $988 million versus the consensus...
Investing.com - Elanco Animal Health (NYSE: ELAN) reported fourth quarter EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $988M...